¡Ya estamos en ! Descubre más
icono de DVLT

DATAVAULT AI INC
DVLT

Dejó de cotizar

DVLT dejó de cotizar en bolsa el 16 de noviembre de 2026.

 

Acerca de: DATAVAULT AI INC

Noticias

Positivo
Neutral
Negativo
Sentimiento 3 meses
Positivo 0.8%
Neutral 98.4%
Negativo 0.8%
Neutral
GlobeNewsWire
ayer
JP3E Holdings' Subsidiary Completes $2,000,000 Delivery of a Strategic Metals Platform
TRENTON, N.J., Nov. 17, 2026 (GLOBE NEWSWIRE) -- JP3E Holdings Inc. (OTC: JPTE) (“JP3E” or the “Company”) today announced that its wholly owned subsidiary, Demora Foundation Inc. (“Demora”), delivered Patriot SMAP v1.0 to Patriot Strategic Metals LLC (“PSM”) under a consolidated $2 million platform development and services program.
JP3E Holdings' Subsidiary Completes $2,000,000 Delivery of a Strategic Metals Platform
Neutral
Business Wire
hace 5 días
Datavault AI Receives Notice of Nasdaq Trading Suspension; Common Stock Eligible to Trade on OTC Markets
PHILADELPHIA--(BUSINESS WIRE)--Datavault AI Inc. (“Datavault” or the “Company”) (OTC: DVLT), today announced that the Company expects its common stock will be eligible to trade on the over-the-counter market (“OTC Markets”) effective with the open of the market on November 17, 2026. The move to OTC Markets follows Nasdaq's decision to suspend trading in the Company's common stock effective November 17, 2026, due to the Company's non-compliance with Nasdaq's $1.00 minimum bid price requirement se.
Datavault AI Receives Notice of Nasdaq Trading Suspension; Common Stock Eligible to Trade on OTC Markets
Neutral
Business Wire
hace 9 días
Datavault AI and Biochar Now Combine Insured Carbon Removal Credits with Patented Tokenization Technology
PHILADELPHIA--(BUSINESS WIRE)--Datavault AI Inc. (“Datavault” or the “Company”) (Nasdaq: DVLT), today announced a global strategic collaboration with Biochar Now to expand the distribution of verified, insured carbon removal credits through Datavault's patented tokenization technology and global marketing and distribution capabilities. The partnership is designed to connect Biochar Now's carbon removal credits with a broader network of buyers while strengthening transparency, traceability and a.
Datavault AI and Biochar Now Combine Insured Carbon Removal Credits with Patented Tokenization Technology
Neutral
PRNewsWire
hace 12 días
Datavault AI Founder Nathaniel Bradley Sues Board
WILMINGTON, Del., Nov. 6, 2026 /PRNewswire/ -- Lawsuit Alleges Chairman and CFO Brett Moyer Engineered a Weekend Lockout While Keeping a $90–$100 Million Financing Offer From Independent Directors Datavault AI Founder Nathaniel Bradley Sues Board Nathaniel Bradley, the founder whose technology became Nasdaq-listed Datavault AI Inc. (NASDAQ: DVLT), today filed a lawsuit in the Delaware Court of Chancery asking the court to declare his contested ouster as CEO void and restore him to office.
Datavault AI Founder Nathaniel Bradley Sues Board
Positivo
Benzinga
hace 12 días
Datavault AI Stock Rallies After Board Fires CEO, Several Execs Replaced
Datavault AI Inc. (NASDAQ:DVLT) shares jumped Friday after the company moved its finance chief, Brett Moyer, into the CEO role, capping a turbulent stretch that began with a warning about its books.
Datavault AI Stock Rallies After Board Fires CEO, Several Execs Replaced
Neutral
Business Wire
hace 12 días
Datavault Board of Directors Appoints Brett Moyer as Chief Executive Officer and President; Names Kimberly Briskey Chair of the Board
PHILADELPHIA--(BUSINESS WIRE)--Datavault AI Inc. (“Datavault” or the “Company”) (Nasdaq: DVLT) today announced that its Board of Directors has appointed Brett Moyer as Chief Executive Officer and President, Kimberly Briskey as Chair of the Board, Sri Peruvemba as Vice Chair of the Board, Teri Gallo as Chief Operating Officer, Stanley Mbugua as Chief Financial Officer and Christopher R. Hardt as Chair of the Audit Committee, effective immediately. Mr. Moyer succeeds Nathaniel Bradley, who was re.
Datavault Board of Directors Appoints Brett Moyer as Chief Executive Officer and President; Names Kimberly Briskey Chair of the Board
Negativo
Benzinga
hace 22 días
Datavault AI Stock Crashes — Financials Cannot Be Trusted: What You Need to Know
Shares of Datavault AI Inc. (NASDAQ:DVLT) fell nearly 40% after the company told investors to stop relying on financial results stretching back to the third quarter of 2025.
Datavault AI Stock Crashes — Financials Cannot Be Trusted: What You Need to Know
Neutral
Business Wire
hace 27 días
Datavault AI Signs Non-Binding Letter of Intent to Acquire a 19.9% Equity Stake in DataMEDS AI in Consideration of an Expanded Technology License
PHILADELPHIA--(BUSINESS WIRE)--Datavault AI Inc. (“Datavault AI” or the “Company”) (Nasdaq: DVLT), an Artificial Intelligence Platform (“AIP”) company providing data monetization, credentialing, and real-world asset (“RWA”) tokenization, today announced that it has entered into a non-binding letter of intent (“LOI”) to acquire a 19.9% equity interest in DataMEDS AI, Inc. (NASDAQ: MEDS) (“DataMEDS”) in consideration of an expansion of its existing technology license with DataMEDS. The proposed t.
Datavault AI Signs Non-Binding Letter of Intent to Acquire a 19.9% Equity Stake in DataMEDS AI in Consideration of an Expanded Technology License
Neutral
Accesswire
hace 29 días
DataMeds Regains Compliance With NASDAQ Listing Standards
TAMPA, FL / ACCESS Newswire / October 20, 2026 / DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMeds AI," "DataMEDS SI," "DataMEDS," or the "Company"), a healthcare company leveraging its Health IT and physical infrastructure together with its super intelligence (artificial intelligence) platform EinsteinRx™ and smart contracts platform PharmacyChain™, today announced that it has received a notification letter (the "Compliance Notice") from the Listing Qualifications Staff of the Nasdaq Stock Market, LLC ("Nasdaq") dated October 19, 2026, informing DataMEDS that it has regained compliance with Nasdaq Listing Rule 5550(b)(1) (the "Equity Rule"). In order to regain compliance with the Equity Rule, DataMEDS needed to have a minimum stockholders' equity of $2.5 million.
DataMeds Regains Compliance With NASDAQ Listing Standards
Neutral
Accesswire
el mes pasado
DataMeds Applauds FDA's Proposed Interim Access Policy for Compounding Using Certain Peptides and Provides Corexa Health's Peptides Roadmap
Corexa Health's three divisions - pharmacy, distribution, and tech & hub - positioned to serve the emerging compounded peptide market TAMPA, FL / ACCESS Newswire / October 16, 2026 / DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMeds AI," "DataMEDS SI," "DataMEDS," or the "Company"), a healthcare company leveraging its Health IT and physical infrastructure together with its super intelligence platform EinsteinRx™ and smart contracts platform PharmacyChain™, today applauded the issuance of a new policy proposal by the U.S. Food and Drug Administration (FDA) entitled "Interim Access Policy for Compounding Using Certain Peptides." The new proposed policy comes less than three months following the recommendation from FDA's Pharmacy Compounding Advisory Committee (PCAC) to loosen restrictions on the use of six peptides.
DataMeds Applauds FDA's Proposed Interim Access Policy for Compounding Using Certain Peptides and Provides Corexa Health's Peptides Roadmap
Gráficos de precios implementados con Lightweight Charts™